BridgeMD
Compares treatment options for Adenocarcinoma of the Colon
Official title Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery
ClinicalTrials.gov ID: NCT07129512
What this study is testing
- What it's testing
- INTRODUCTION Colorectal cancer rates are rising, with surgery emphasizing radical resection and vessel ligation. Conventional methods using clips pose risks of bleeding and complications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 80
You may be able to join if
- Adults 19 to 80 years of age
- Patients with histologically confirmed pathologic adenocarcinoma of the colon
- Patients with an ECOG score between 0 and 2
- Patients with a preoperative ASA score of I to III
- Patients without a history of surgery for abdominal malignancies
You likely can't join if
- Patients with an ASA score of 4 or higher
- People with blood clotting disorders such as liver cirrhosis, end-stage renal failure, or hematologic disorders
- Pregnant women
- Mentally ill patients who have difficulty giving informed consent
- Preoperative blood hemoglobin (Hb) less than 7 g/dL
- Patients taking anticoagulants before or after surgery
See the full eligibility criteria
- Adults 19 to 80 years of age
- Patients with histologically confirmed pathologic adenocarcinoma of the colon
- Patients with an ECOG score between 0 and 2
- Patients with a preoperative ASA score of I to III
- Patients without a history of surgery for abdominal malignancies
- Patients with no history of anticoagulation prior to surgery
- Patients who understand the study process and treatment plan and are able to complete the informed consent form themselves
- Patients with an ASA score of 4 or higher
- People with blood clotting disorders such as liver cirrhosis, end-stage renal failure, or hematologic disorders
- Pregnant women
- Mentally ill patients who have difficulty giving informed consent
- Preoperative blood hemoglobin (Hb) less than 7 g/dL
- Patients taking anticoagulants before or after surgery
- Patients who have undergone emergency surgery
- Patients who are unable to be followed up on an outpatient basi
- No Informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.